Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Heckman

Showing results (101-110 of 131) with videos related to

Pageof 14
Sort By:
Journal of Environmental and Public Health|June 22, 2012
Impact of tobacco control interventions on smoking initiation, cessation, and prevalence: a systematic reviewLisa M Wilson, Erika Avila Tang, Geetanjali Chander, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 22, 2024
Implementation of clopidogrel pharmacogenetic clinical decision support for a preemptive return of results programChristina L Aquilante, Katy E Trinkley, Yee Ming Lee, et al.
JAMA|June 15, 2026
Lifestyle and Metformin Interventions and Risk of Multimorbidity in Adults With PrediabetesMarcel E Salive, Ashley H Tjaden, Jesse R Ames, et al.
Elife|November 26, 2019
Novel charged sodium and calcium channel inhibitor active against neurogenic inflammationSeungkyu Lee, Sooyeon Jo, Sébastien Talbot, et al.
Diabetologia|August 4, 2017
Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes StudyVanita R Aroda, William C Knowler, Jill P Crandall, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 17, 2025
Randomized Study of Metformin and Intensive Lifestyle Intervention on Cancer Incidence over 21 years of follow-up in the Diabetes Prevention ProgramBrandy M Heckman-Stoddard, Jill P Crandall, Sharon L Edelstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2016
Mammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and ImplicationsMaeve Mullooly, Ruth M Pfeiffer, Sarah J Nyante, et al.
NPJ Breast Cancer|June 9, 2025
Window-of-opportunity trials to screen effective agents and optimize dose in breast cancer preventionG Aurilio, D Serrano, M Lazzeroni, et al.
The American Journal of Clinical Nutrition|July 17, 2025
The 2018 World Cancer Research Fund/American Institute for Cancer Research Score and Cancer Risk: results from the diabetes prevention program outcomes studyAshley H Tjaden, Audrey A Goldbaum, Sharon L Edelstein, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 6, 2019
A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose, and Steady-State Pharmacokinetic Study of 9cUAB30 in Healthy VolunteersJill M Kolesar, Shannon Andrews, Heather Green, et al.
Pageof 14

Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
Journal of Environmental and Public Health|June 22, 2012
Impact of tobacco control interventions on smoking initiation, cessation, and prevalence: a systematic reviewLisa M Wilson, Erika Avila Tang, Geetanjali Chander, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 22, 2024
Implementation of clopidogrel pharmacogenetic clinical decision support for a preemptive return of results programChristina L Aquilante, Katy E Trinkley, Yee Ming Lee, et al.
JAMA|June 15, 2026
Lifestyle and Metformin Interventions and Risk of Multimorbidity in Adults With PrediabetesMarcel E Salive, Ashley H Tjaden, Jesse R Ames, et al.
Elife|November 26, 2019
Novel charged sodium and calcium channel inhibitor active against neurogenic inflammationSeungkyu Lee, Sooyeon Jo, Sébastien Talbot, et al.
Diabetologia|August 4, 2017
Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes StudyVanita R Aroda, William C Knowler, Jill P Crandall, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 17, 2025
Randomized Study of Metformin and Intensive Lifestyle Intervention on Cancer Incidence over 21 years of follow-up in the Diabetes Prevention ProgramBrandy M Heckman-Stoddard, Jill P Crandall, Sharon L Edelstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2016
Mammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and ImplicationsMaeve Mullooly, Ruth M Pfeiffer, Sarah J Nyante, et al.
NPJ Breast Cancer|June 9, 2025
Window-of-opportunity trials to screen effective agents and optimize dose in breast cancer preventionG Aurilio, D Serrano, M Lazzeroni, et al.
The American Journal of Clinical Nutrition|July 17, 2025
The 2018 World Cancer Research Fund/American Institute for Cancer Research Score and Cancer Risk: results from the diabetes prevention program outcomes studyAshley H Tjaden, Audrey A Goldbaum, Sharon L Edelstein, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 6, 2019
A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose, and Steady-State Pharmacokinetic Study of 9cUAB30 in Healthy VolunteersJill M Kolesar, Shannon Andrews, Heather Green, et al.
Pageof 14